Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CC260, a selective inhibitor for PI5P4Kα and PI5P4Kβ with Kis of 40 nM and 30 nM respectively, exhibits minimal to no inhibition against other protein kinases like Plk1 and RSK2. It is applicable in the research of cell energy metabolism, diabetes, and cancer[1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,370.00 | |
50 mg | 6-8 weeks | $ 1,790.00 | |
100 mg | 6-8 weeks | $ 2,800.00 |
Description | CC260, a selective inhibitor for PI5P4Kα and PI5P4Kβ with Kis of 40 nM and 30 nM respectively, exhibits minimal to no inhibition against other protein kinases like Plk1 and RSK2. It is applicable in the research of cell energy metabolism, diabetes, and cancer[1]. |
Targets&IC50 | PI5P4Kα:40 nM (Ki), PI5P4Kβ:30 nM (Ki) |
In vitro | In cultured C2C12 myotubes, CC260 (20 μM) not only enhances insulin-induced phosphorylation of Akt at Thr-308 and Ser-473, but also inhibits S6K phosphorylation (Thr-389) mediated by mTORC1[1]. Furthermore, CC260, at concentrations ranging from 2.5 μM to 20 μM, progressively increases acetyl-CoA carboxylase (ACC) phosphorylation in a dose-dependent manner[1]. CC260 treatment diminishes the survival of BT474 cells under serum starvation, a condition that can be reversed by introducing a PI5P4Kβ resistant mutant[1]. Additionally, in BT474 cells, CC260 leads to an augmentation in glycolytic ATP production[1]. |
Molecular Weight | 490.43 |
Formula | C24H29Cl2N5O2 |
CAS No. | 2411088-26-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CC260 2411088-26-9 CC 260 CC-260 inhibitor inhibit